Danish biotechnology company Orphazyme, owned by Novo Nordisk's holding company Novo Holding (19.2%), Sunstone Life Science Ventures (9.1%) and Aescap Venture Management (8.9%), has listed on the Nasdaq Copenhagen exchange.
Bid Equity began its social care and healthcare software buy-and-build strategy in 2017
Marfin has received a binding offer from CVC and granted the GP an exclusivity period until 6 November
Firms invested in the business in 2015 alongside management, acquiring it from Initiative & Finance
Healthtech company has raised $34.2m since being founded six years ago